<DOC>
	<DOCNO>NCT01423955</DOCNO>
	<brief_summary>The purpose study evaluate potential erythropoietin reduce risk degree acute kidney injury cardiac surgery .</brief_summary>
	<brief_title>Erythropoietin ( EPO ) Protect Renal Function After Cardiac Surgery</brief_title>
	<detailed_description>Acute kidney injury common complication cardiac surgery associate decrease long-term survival . Several experimental animal study show cytoprotective , precondition anti-apoptotic effect high dose erythropoietin . Clinical study human also suggest high dose erythropoietin precondition effect injury ischemia reperfusion different organ human , brain , heart , liver , kidney . Administration Epo high dos conjunction cardiac surgery show safe direct side-effects . The investigator therefore hypothesize precondition effect erythropoietin cardiac surgery reduce level renal dysfunction surgery group preoperative renal impairment .</detailed_description>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Epoetin Alfa</mesh_term>
	<criteria>The patient schedule nonemergent CABG surgery . CyC eGFR MDRD eGFR &lt; 60 ml/min . The patient give his/her write consent participate The patient uncontrolled hypertension . Hypersensitivity active drug . The patient pregnant fertile woman ( &lt; 50 year ) . The patient treat Erythropoietin within 4 week prior surgery . Preoperative CyC eGFR MDRD eGFR &lt; 15 , patient treat dialysis . The patient know malignancy . The patient plan Offpump CABG surgery . The patient include ongoing clinical trial . Yes / No Clinically judgment investigator patient participate study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>Erythropoietin</keyword>
	<keyword>Erythropoetin</keyword>
	<keyword>Cardiac surgery</keyword>
	<keyword>Ischemia</keyword>
	<keyword>Reperfusion</keyword>
	<keyword>Renal function</keyword>
	<keyword>Cystatin C</keyword>
	<keyword>Creatinine</keyword>
	<keyword>Safety</keyword>
</DOC>